JAGUAR HEALTH, INC. Increase (Decrease) in Due to Related Parties, Current
JAGUAR HEALTH, INC. (JAGX) reported Increase (Decrease) in Due to Related Parties, Current of -$164.65 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-04-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2019-04-10
- JAGUAR HEALTH, INC. increase (decrease) in due to related parties, current for the quarter ending 2017-12-31 was $0.00.
- JAGUAR HEALTH, INC. increase (decrease) in due to related parties, current for the quarter ending 2017-09-30 was -$242.27K.
- JAGUAR HEALTH, INC. increase (decrease) in due to related parties, current for the quarter ending 2017-06-30 was -$602.00, a 123.64% decline year-over-year.
- JAGUAR HEALTH, INC. increase (decrease) in due to related parties, current for the quarter ending 2017-03-31 was $78.23K, a 11879.48% increase year-over-year.
- JAGUAR HEALTH, INC. increase (decrease) in due to related parties, current for fiscal 2017 was -$164.65K.
- JAGUAR HEALTH, INC. increase (decrease) in due to related parties, current for fiscal 2016 was -$296.45K.
- JAGUAR HEALTH, INC. increase (decrease) in due to related parties, current for fiscal 2015 was -$19.78K.
- JAGUAR HEALTH, INC. increase (decrease) in due to related parties, current for fiscal 2014 was -$99.80K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | -$242.27K derived: sum of 2 quarters · filed 2019-04-10 | -$242.87K derived: sum of 3 quarters · filed 2019-04-10 | -$164.65K 10-K · filed 2019-04-10 |
| 2017-09-30 | -$242.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | -$242.87K derived: sum of 2 quarters · filed 2018-11-19 | -$164.65K 10-Q · filed 2018-11-19 | -$191.23K derived: sum of 4 quarters · filed 2018-11-19 |
| 2017-06-30 | -$602.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $77.62K 10-Q · filed 2018-08-13 | $51.04K derived: sum of 3 quarters · filed 2018-08-13 | -$222.02K derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $78.23K 10-Q · filed 2018-05-15 | $51.64K derived: sum of 2 quarters · filed 2018-05-15 | -$221.42K derived: sum of 3 quarters · filed 2018-05-15 | -$218.88K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$26.59K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | -$299.65K derived: sum of 2 quarters · filed 2018-04-09 | -$297.10K derived: sum of 3 quarters · filed 2018-04-09 | -$296.45K 10-K · filed 2018-04-09 |
| 2016-09-30 | -$273.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | -$270.52K derived: sum of 2 quarters · filed 2017-11-20 | -$269.86K 10-Q · filed 2017-11-20 | -$268.85K derived: sum of 4 quarters · filed 2017-11-20 |
| 2016-06-30 | $2.55K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-08-09 | $3.20K 10-Q · filed 2017-08-09 | $4.21K derived: sum of 3 quarters · filed 2017-08-09 | $5.23K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $653.00 10-Q/A · filed 2017-06-23 | $1.66K derived: sum of 2 quarters · filed 2017-06-23 | $2.69K derived: sum of 3 quarters · filed 2017-06-23 | -$23.79K derived: sum of 4 quarters · filed 2017-06-23 |
| 2015-12-31 | $1.01K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $2.04K derived: sum of 2 quarters · filed 2017-02-15 | -$24.44K derived: sum of 3 quarters · filed 2017-02-15 | -$19.78K 10-K · filed 2017-02-15 |
| 2015-09-30 | $1.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$25.45K derived: sum of 2 quarters · filed 2016-11-14 | -$20.79K 10-Q · filed 2016-11-14 | -$75.97K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$26.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$21.82K 10-Q · filed 2016-08-15 | -$77.00K derived: sum of 3 quarters · filed 2016-08-15 | -$68.29K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $4.66K 10-Q · filed 2016-05-10 | -$50.52K derived: sum of 2 quarters · filed 2016-05-10 | -$41.81K derived: sum of 3 quarters · filed 2016-05-10 | -$59.61K derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | -$55.18K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$46.47K derived: sum of 2 quarters · filed 2016-03-29 | -$64.28K derived: sum of 3 quarters · filed 2016-03-29 | -$99.80K 10-K · filed 2016-03-29 |
| 2014-09-30 | $8.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$9.10K derived: sum of 2 quarters · filed 2015-11-13 | -$44.62K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | -$17.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$53.33K 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | -$35.53K 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |